Pharmacy Articles

Pharmacy

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Kim SH et al. – The case indicates the role of gemcitabine as a neoadjuvant chemotherapeutic agent for cholangiocarcinoma and guarantees a randomized controlled prospective study.

Related Articles

Surgical Management of Infrahilar/Suprapancreatic Cholangiocarcinoma: an Analysis of the Surgical Procedures, Surgical Margins, and Survivals of 77 Patients
Journal of Gastrointestinal Surgery, 11/13/09    Relevance Score: 87%

CD10+ fibroblasts are more involved in the progression of hilarextrahepatic cholangiocarcinoma than of peripheral intrahepatic cholangiocarcinoma
Histopathology, 10/15/09    Relevance Score: 87%

Surgical treatment of hilar cholangiocarcinoma in the new era
Journal of Hepato-Biliary-Pancreatic Surgery, 10/27/09    Relevance Score: 85%

Outcome of surgical treatment of hilar cholangiocarcinoma: a special reference to postoperative morbidity and mortality
Journal of Hepato-Biliary-Pancreatic Surgery, 10/13/09    Relevance Score: 85%

Surgical treatment of hilar cholangiocarcinoma in the new era: the Nagoya University experience
Journal of Hepato-Biliary-Pancreatic Surgery, 10/09/09    Relevance Score: 85%


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address